Search clinical trials for: HZT-501
Total 4753 results
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedOsteoarthritis | Rheumatoid Arthritis | Chronic Low Back Pain | Chronic Regional Pain Syndrome | Chronic Soft Tissue PainUnited States
-
University of ZurichCompletedHealth BehaviorSwitzerland
-
SENAI CIMATECRecruiting
-
Hoth Therapeutics, Inc.Worldwide Clinical TrialsRecruitingAcneiform Eruption Due to Chemical | Xerosis Cutis | ParonychiaUnited States
-
HDT BioKaiser Permanente; Rainier Clinical Research Center; C3 Research AssociatesActive, not recruitingSARS-CoV2 InfectionUnited States
-
Terns, Inc.Completed
-
Horizon Pharma USA, Inc.CompletedThyroid-Associated Ophthalmopathy | Thyroid Associated OphthalmopathiesUnited Kingdom, United States, Germany, Italy
-
NewG Lab PharmaActive, not recruitingHepatocellular Carcinoma | Fibrolamellar CarcinomaKorea, Republic of
-
Horizon Pharma USA, Inc.CompletedThyroid Eye DiseaseItaly, United States, Germany
-
HistogenCompleted
-
Horizon Pharma USA, Inc.Approved for marketingThyroid Eye Disease | Graves' OrbitopathyUnited States
-
BiondVax Pharmaceuticals ltd.Completed
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...TerminatedRenal Cell Carcinoma | Hepatocellular CarcinomaAustralia, New Zealand
-
Military Institute of Aviation MedicineNalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy... and other collaboratorsCompletedIschemia | Hypoxia | Orthostatic HypotensionPoland
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
EGEN, Inc.Terminated
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
CKD Bio CorporationCompletedGlabellar LinesKorea, Republic of
-
Horizon Therapeutics USA, Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Horizon Pharma USA, Inc.CompletedThyroid Eye Disease | Graves' OrbitopathyUnited States, Italy, Germany
-
Horizon Therapeutics USA, Inc.CompletedThyroid Eye Disease | Chronic (Inactive) Thyroid Eye DiseaseUnited States
-
Bellicum PharmaceuticalsActive, not recruitingLymphoma | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Myelogenous LeukemiaUnited States
-
EyeGene Inc.Novotech (Australia) Pty LimitedCompletedPrevention of Herpes Zoster (HZ)Australia
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
BiondVax Pharmaceuticals ltd.Completed
-
Cryonove PharmaCEISO; Dermatech; LTD HEALTHCompleted
-
Cryonove PharmaCEISO; Dermatech; Sefako Makgatho Health Sciences UniversityCompletedSolar Lentigo | Post-inflammatory Hyperpigmentation | Senile LentigoSouth Africa
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Bellicum PharmaceuticalsWithdrawnRecurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Myelodysplastic... and other conditionsUnited States
-
Dermavant Sciences GmbHCompletedAtopic DermatitisCanada, United States
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.Active, not recruitingMajor Depressive DisorderUnited States
-
University of California, Los AngelesCompleted
-
Amicus TherapeuticsActive, not recruitingBatten Disease | CLN6United States
-
Chong Kun Dang PharmaceuticalCompletedHealthy | Renal ImpairmentKorea, Republic of
-
Otsuka Pharmaceutical Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaTaiwan, Korea, Republic of, Japan
-
SensorionNot yet recruitingOtorhinolaryngologic Diseases | Ear Diseases | Hearing Disorders | Deafness | Hearing Loss, Sensorineural | Congenital Deafness | DFNB9 | OTOF Gene MutationFrance
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedLiver DysfunctionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Neurotech PharmaceuticalsThe Emmes Company, LLC; The Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedOsteoarthritis | Rheumatoid Arthritis | Chronic Low Back Pain | Chronic Regional Pain Syndrome | Chronic Soft Tissue PainUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompleted
-
Medigen Vaccine Biologics Corp.CompletedH7N9 Influenza VaccineTaiwan
-
Stanford UniversityRecruitingGlaucomaUnited States
-
Bellicum PharmaceuticalsActive, not recruitingLymphoma | Myelodysplastic Syndromes | Leukemia | Hematologic Neoplasms | Multiple MyelomaUnited States
-
Beacon TherapeuticsEnrolling by invitationX-Linked Retinitis PigmentosaUnited States